Clinical Trial Equipment And Ancillary Solutions Market Report 2026

Clinical Trial Equipment And Ancillary Solutions Market Overview

• Clinical Trial Equipment And Ancillary Solutions market size has reached to $2.77 billion in 2025 • Expected to grow to $4.09 billion in 2030 at a compound annual growth rate (CAGR) of 7.9% • Growth Driver: The Rising Prevalence Of Chronic Diseases Driving Growth In The Clinical Trial Equipment And Ancillary Solutions Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Clinical Trial Equipment And Ancillary Solutions Market?

Clinical trial equipment and ancillary solutions refer to a broad range of products, services, and support systems utilized in clinical research to facilitate the planning, execution, and management of clinical trials. These solutions are necessary for conducting safe, efficient, and compliant clinical studies across different therapeutic areas and phases of drug development. The clinical trial equipment and ancillary solutions support the successful planning, execution, and completion of clinical trials, ultimately contributing to the advancement of medical science and improved patient care. The main types of clinical trial equipment and ancillary solutions are diagnostic equipment, laboratory instruments, and ancillary solutions. Diagnostic equipment are specialized devices used in clinical trials to detect, diagnose, or monitor health conditions or the effects of treatments. The various services include rental and leasing services, supply and logistics services, regulatory compliance services, and software services that are used by various end-users such as pharmaceutical and biotechnology companies, contract research organizations (CROs), medical device companies, others

What Is The Clinical Trial Equipment And Ancillary Solutions Market Growth Forecast?

The clinical trial equipment and ancillary solutions market size is expected to see strong growth in the next few years. It will grow to $4.09 billion in 2030 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to increasing adoption of decentralized and hybrid trials, rising demand for real-time trial data monitoring, expansion of digital health technologies in trials, growing focus on patient-centric trial designs, increasing regulatory complexity in clinical research. Major trends in the forecast period include increasing adoption of integrated clinical trial management systems, rising use of digital and remote trial equipment, growing demand for ancillary logistics and support services, expansion of decentralized clinical trial solutions, enhanced focus on regulatory-compliant trial infrastructure.

Global Clinical Trial Equipment And Ancillary Solutions Market Segmentation

1) By Type: Diagnostic Equipment, Laboratory Instruments, Ancillary Solutions 2) By Service: Rental And Leasing Services, Supply And Logistics Services, Regulatory Compliance Services, Software Services 3) By End-User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations (CROs), Medical Device Companies, Others End-Users Subsegments: 1) By Diagnostic Equipment: Imaging Devices, Electrocardiogram (ECG) Machines, Blood Pressure Monitors, Pulse Oximeters 2) By Laboratory Instruments: Centrifuges, Spectrometers, Microscopes, Pipettes And Dispensers 3) By Ancillary Solutions: Clinical Trial Management Software (CTMS), Patient Recruitment Solutions, Data Management Solutions, Temperature Control Systems

What Are The Drivers Of The Clinical Trial Equipment And Ancillary Solutions Market?

The increasing prevalence of chronic diseases is expected to propel the growth of the clinical trial equipment and ancillary solutions market going forward. Chronic disease is a long-lasting condition that typically requires ongoing medical attention and can limit daily activities or quality of life. The prevalence of chronic diseases is due to exposure to air pollution, chemicals, toxins, lifestyle changes, and genetic factors. Clinical trial equipment and ancillary solutions are invaluable tools for improving outcomes in chronic disease patients by enabling early detection, personalized treatment approaches, objective assessment of treatment efficacy, safety monitoring, patient engagement, optimized trial design, regulatory compliance, and research collaboration. For instance, in April 2025, according to the Centers for Disease Control and Prevention (CDC), a US-based federal agency, in 2023, approximately 194 million U.S. adults, or 76.4%, reported having at least one chronic condition. The prevalence was 59.5% among young adults, 78.4% among midlife adults, and 93.0% among older adults. Therefore, the increasing prevalence of chronic diseases drives the clinical trial equipment and ancillary solutions industry. The rising healthcare expenditure is expected to propel the growth of the clinical trial equipment and ancillary solutions market going forward. Healthcare expenditure refers to the total financial resources spent by individuals, organizations, or governments on preventing, treating, and managing health conditions. Healthcare expenditure is increasing due to advancements in medical technology, as new diagnostic tools, treatments, and innovative therapies often come at higher costs, leading to greater overall spending in healthcare. Increasing healthcare expenditure drives the demand for clinical trial equipment and ancillary solutions by enabling more clinical research, adoption of advanced technologies, compliance with regulatory standards, and expansion into diverse therapeutic areas. For instance, in December 2024, according to the Centers for Medicare & Medicaid Services, a US-based agency responsible for administering the Medicare and Medicaid programs, in 2023, U.S. health care expenditures increased by 7.5%, climbing to $4.9 trillion, or roughly $14,570 for each individual. Therefore, the rising healthcare expenditure is driving the growth of the clinical trial equipment and ancillary solutions industry.

Key Players In The Global Clinical Trial Equipment And Ancillary Solutions Market

Major companies operating in the clinical trial equipment and ancillary solutions market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Agilent Technologies Inc., Iron Mountain Incorporated (IRM), PerkinElmer Inc., Illumina Inc., Sartorius AG, PAREXEL International Corp., Marken, Shimadzu Corporation, Waters Corporation, Bruker Corporation, Eppendorf AG, Tecan Group AG, Mettler Toledo International Inc., Hamilton Company, Repligen Corporation, Labconco Corporation, Ancillare LP, Binder GmbH, Germfree Laboratories Inc., Nuaire Inc., Sheldon Manufacturing Inc., Esco Micro Pte. Ltd.

What Are Latest Mergers And Acquisitions In The Clinical Trial Equipment And Ancillary Solutions Market?

In March 2024, Myonex, a US-based pharmaceutical company, acquired Creapharm Group for an undisclosed amount. With this acquisition, Myonex aims to enhance its service offerings and capabilities for pharmaceutical and biotech companies by integrating CREAPHARM’s clinical packaging, distribution, and bio services, thereby providing more agile and reliable solutions for clients navigating both clinical and commercial stages, including those managing Advanced Therapies. Creapharm is a France-based pharmaceutical technology company that offers clinical trial equipment, and ancillary solutions.

Regional Outlook

North America was the largest region in the clinical trial equipment and ancillary solutions market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Clinical Trial Equipment And Ancillary Solutions Market?

The clinical trial equipment and ancillary solutions market consists of revenues earned by entities by providing services such as clinical trial supply services, laboratory services, data management and technology solutions, regulatory and compliance services, and training and support services. The market value includes the value of related goods sold by the service provider or included within the service offering. The clinical trial equipment and ancillary solutions market also includes sales of auditing tools, inventory management tools, and safety signal detection tools. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Clinical Trial Equipment And Ancillary Solutions Market Report 2026?

The clinical trial equipment and ancillary solutions market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the clinical trial equipment and ancillary solutions industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.